Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
52 stocks in the UK match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| 4BB.L | 4basebio PLC | Healthcare | $99.96M | 470.00 GBP | −48.91% | −10.48% |
| 88Q.DE | 4basebio PLC | Healthcare | $96.59M | 5.35 EUR | −46.50% | −3.60% |
| EAH.L | ECO Animal Health Group plc | Healthcare | $89.77M | 99.00 GBP | −15.31% | +1.54% |
| CREO.L | Creo Medical Group PLC | Healthcare | $85.82M | 12.88 GBP | −30.41% | −5.50% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| POLB.L | Poolbeg Pharma PLC | Healthcare | $82.41M | 8.60 GBP | −6.52% | +36.51% |
| OKYO | OKYO Pharma Limited | Healthcare | $81.34M | $1.55 | −51.56% | −5.49% |
| KOO.L | Kooth plc | Healthcare | $72.00M | 146.00 GBP | −23.16% | −3.63% |
| STX.L | Shield Therapeutics plc | Healthcare | $71.97M | 4.85 GBP | −61.20% | −15.65% |
| SAR.L | Sareum Holdings plc | Healthcare | $70.10M | 37.00 GBP | −2.63% | +76.19% |
| HVO.L | hVIVO plc | Healthcare | $59.87M | 6.50 GBP | −40.91% | −10.34% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | Healthcare | $54.52M | 588.00 GBP | −67.33% | −8.12% |
| OHGR.L | One Health Group Plc | Healthcare | $53.82M | 292.50 GBP | −2.50% | +10.38% |
| COIL.L | Coiled Therapeutics plc | Healthcare | $49.30M | 9.50 GBP | −68.33% | −9.52% |
| MREO | Mereo BioPharma Group plc | Healthcare | $44.39M | $0.28 | −88.27% | −10.03% |
| MPAL.L | MedPal AI PLC | Healthcare | $44.20M | 3.75 GBP | −72.22% | +22.95% |
| ABDX.L | Abingdon Health Plc | Healthcare | $36.92M | 10.75 GBP | −17.31% | +4.88% |
| AREC.L | Arecor Therapeutics plc | Healthcare | $33.86M | 66.00 GBP | −34.00% | +3.94% |
| PXS.L | Provexis plc | Healthcare | $32.52M | 1.09 GBP | −29.68% | −7.63% |
| IMM.L | ImmuPharma plc | Healthcare | $31.75M | 3.41 GBP | −82.42% | −24.22% |
| DOC.AX | Doctor Care Anywhere Group PLC | Healthcare | $31.56M | 0.13 AUD | −40.48% | +13.64% |
| GDR.L | genedrive plc | Healthcare | $28.91M | 1.30 GBP | −13.33% | +33.33% |
| GRDX | GridAI Technologies Corp. | Healthcare | $28.75M | $4.04 | −41.69% | +35.12% |
| RENX.L | Renalytix Plc | Healthcare | $25.24M | 4.30 GBP | −72.26% | +62.26% |
| RUA.L | RUA Life Sciences plc | Healthcare | $24.04M | 28.00 GBP | −6.35% | +9.80% |
| IXI.L | IXICO plc | Healthcare | $23.06M | 7.75 GBP | −48.33% | −8.82% |
| COG.L | Cambridge Cognition Holdings Plc | Healthcare | $22.67M | 31.00 GBP | −31.11% | −6.06% |
| IHC.L | Inspiration Healthcare Group plc | Healthcare | $22.54M | 18.30 GBP | −42.81% | −1.08% |
| CLBX.L | CelLBxHealth plc | Healthcare | $19.30M | 1.25 GBP | −84.37% | −1.96% |
| FAB.L | Fusion Antibodies plc | Healthcare | $19.13M | 11.25 GBP | −46.43% | +9.76% |
| THAT.L | Thalia Therapeutics Plc | Healthcare | $15.69M | 0.65 GBP | −35.00% | −3.70% |
| GENF.L | Genflow Biosciences plc | Healthcare | $15.39M | 2.00 GBP | −35.90% | +23.08% |
| APTA.L | Aptamer Group PLC | Healthcare | $15.32M | 0.38 GBP | −76.11% | −21.05% |
| PTRK.ST | Physitrack PLC | Healthcare | $13.83M | 8.06 SEK | −62.86% | −0.49% |
| SVNS.L | Solvonis Therapeutics plc | Healthcare | $11.56M | 0.12 GBP | −69.50% | −11.59% |
| GENI.L | GENinCode Plc | Healthcare | $9.25M | 0.90 GBP | −83.64% | +12.50% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | Healthcare | $8.66M | 1.50 GBP | −61.54% | −26.83% |
| OPTI.L | OptiBiotix Health Plc | Healthcare | $7.93M | 5.65 GBP | −53.88% | −1.74% |
| PRM.L | Proteome Sciences plc | Healthcare | $7.53M | 1.59 GBP | −63.98% | −11.94% |
| VRCI.L | Verici Dx plc | Healthcare | $6.99M | 0.23 GBP | −77.36% | −35.71% |
| OBD.L | Oxford BioDynamics Plc | Healthcare | $6.85M | 0.12 GBP | −83.60% | −1.60% |
| NCNA | NuCana plc | Healthcare | $6.37M | $1.53 | −78.81% | +18.60% |
| CNSL.L | Cambridge Nutritional Sciences plc | Healthcare | $6.14M | 1.90 GBP | −45.71% | +8.57% |
| NFX.L | Nuformix plc | Healthcare | $5.85M | 0.16 GBP | −71.35% | +6.71% |
| TCF.L | Theracryf Plc | Healthcare | $5.55M | 0.19 GBP | −36.67% | −2.56% |
| SUN.L | Surgical Innovations Group plc | Healthcare | $5.39M | 0.43 GBP | −42.41% | −15.00% |
| FDBK.L | Feedback plc | Healthcare | $4.08M | 6.85 GBP | −54.33% | +13.22% |
| PYC.L | Physiomics Plc | Healthcare | $3.17M | 0.52 GBP | −35.63% | +7.29% |
| FUM.L | Futura Medical plc | Healthcare | $3.16M | 0.39 GBP | −96.29% | −2.26% |
| BSFA.L | BSF Enterprise Plc | Healthcare | $3.03M | 1.15 GBP | −71.25% | +43.75% |
| VAL.L | ValiRx plc | Healthcare | $2.78M | 0.16 GBP | −81.74% | +3.33% |
| VRAX | Virax Biolabs Group Limited | Healthcare | $2.21M | $2.77 | −79.00% | −4.15% |
| BDRX | Biodexa Pharmaceuticals Plc | Healthcare | $1.07M | $0.98 | −98.35% | −32.13% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.